The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and Drug Administration. Cobenfy (xanomeline/trospium chloride) could bring patients what they’ve long hoped for: A means of easing the hallucinations and “voices” that disrupt their lives without the weight gain and sluggishness of current… read on > read on >
In a sign that climate change may be fueling heat illnesses in kids, a new study reveals that such visits to two Texas children’s emergency rooms spiked 170% between 2012 and 2023. Study leader Dr. Taylor Merritt, a resident pediatrician at UT Southwestern Medical Center in Dallas, is to present the findings Sunday at the… read on > read on >
Folks who depend on e-bikes and powered scooters to get around know they might get hurt, but they might be surprised by just how likely that really is. Rates of injury on the trendy transportation devices skyrocketed between 2019 and 2022, Columbia University researchers report. E-bike injuries jumped 293%; those involving powered scooters were up… read on > read on >
Babies conceived through assisted reproductive technology are more likely to be born with a major heart defect, new research shows. That risk was 36% higher in babies conceived through techniques such as in vitro fertilization (IVF). Some congenital heart defects are life-threatening. The increased risk is especially pronounced with multiple births, which are more common… read on > read on >
Grandma’s pill organizer. Fido’s pain medication. A tossed-away tissue. All are potential sources of opioid poisoning for young children, researchers at the New Jersey Poison Control Center report. Their five-year look at 230 cases of opioid exposure in children between 1 month and 6 years of age shows how easily they get their hands on… read on > read on >
Patients with opioid use disorder who receive higher doses of a drug to treat their addiction are more likely to have positive results, a new study finds. Daily doses of the drug buprenorphine is a standard treatment for opioid use disorder, and the findings suggest that higher doses may be a better way to manage… read on > read on >
.jpeg)
An experimental monoclonal antibody treatment appears to ease the digestive disorder ulcerative colitis in patients who’ve failed other medications, a new trial shows. The treatment, tulisokibart, spurred remission of symptoms in more than a quarter of patients, compared to only 1.5% of those taking a placebo, an international group of researchers reported Sept. 26 in… read on > read on >
If you think it isn’t important to start breastfeeding your newborn while still in the hospital, think again. New research shows that infants who were exclusively fed breast milk during their hospitalization right after birth were 22% less likely to develop asthma in early childhood. The findings, to be presented Sunday at the American Academy… read on > read on >
Laws that ban assault weapons do indeed protect children from dying in mass shootings, but the same can’t be said for more common types of gun restrictions and regulations, new research shows. “Mass shootings are horrific events. We found that large capacity magazine bans may have the biggest effect on reducing child deaths in mass… read on > read on >
Bacteria that causes gum disease can also raise a person’s risk of head and neck cancers, a new study says. More than a dozen bacterial species have been linked to a collective 50% increased risk of head and neck cancer, researchers found. “Our results offer yet another reason to keep up good oral hygiene habits,”… read on > read on >
